HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Knockdown of protein tyrosine phosphatase SHP-1 inhibits G1/S progression in prostate cancer cells through the regulation of components of the cell-cycle machinery.

Abstract
SHP-1, a haematopoietic cell-specific tyrosine phosphatase, is also expressed in human prostate. In this study, we report that SHP-1 depletion in PC-3 cells induced by small interfering RNAs causes G1 phase cell-cycle arrest accompanied by changes in some components of the cell-cycle machinery. SHP-1 knockdown increases p27(Kip1) (p27) protein stability, its nuclear localization and p27 gene transcription. These effects could be mediated by PI3K-AKT pathway as SHP-1 interacts with PI3K regulating its activity and p110 catalytic subunit phosphorylation. The increase in p27 protein stability could also because of reduced cyclin-dependent kinase (CDK2) activity. SHP-1 knockdown decreases the CDK6 levels, inducing retinoblastoma protein hypophosphorylation, downregulation of cyclin E and thereby a decrease in the CDK2 activity. However, the codepletion of SHP-1 and p27 does not produce re-entry into the cycle, implying that p27 is not required to maintain cell-cycle arrest induced by SHP-1 depletion. The maintenance of the PC-3 cell anti-proliferative response after p27 loss could be because of mislocalization of CDK2 induced by SHP-1 knockdown. This study shows that SHP-1 depletion promotes cell-cycle arrest by modulating the activity of cell-cycle regulators and suggests that SHP-1 may be required for the proper functioning of events governing cell-cycle progression.
AuthorsF J Rodríguez-Ubreva, A E Cariaga-Martinez, M A Cortés, M Romero-De Pablos, S Ropero, P López-Ruiz, B Colás
JournalOncogene (Oncogene) Vol. 29 Issue 3 Pg. 345-55 (Jan 21 2010) ISSN: 1476-5594 [Electronic] England
PMID19838216 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Cell Cycle Proteins
  • Cyclin E
  • Retinoblastoma Protein
  • Cyclin-Dependent Kinase Inhibitor p27
  • Luciferases
  • CDK2 protein, human
  • CDK6 protein, human
  • Cyclin-Dependent Kinase 2
  • Cyclin-Dependent Kinase 6
  • PTPN6 protein, human
  • Protein Tyrosine Phosphatase, Non-Receptor Type 6
Topics
  • Blotting, Western
  • Cell Cycle (genetics, physiology)
  • Cell Cycle Proteins (genetics, metabolism)
  • Cell Line, Tumor
  • Cell Nucleus (metabolism)
  • Cell Proliferation
  • Cyclin E (genetics, metabolism)
  • Cyclin-Dependent Kinase 2 (genetics, metabolism)
  • Cyclin-Dependent Kinase 6 (genetics, metabolism)
  • Cyclin-Dependent Kinase Inhibitor p27 (genetics, metabolism)
  • G1 Phase
  • Gene Expression Regulation, Neoplastic
  • Humans
  • Luciferases (genetics, metabolism)
  • Male
  • Phosphorylation
  • Promoter Regions, Genetic (genetics)
  • Prostatic Neoplasms (genetics, metabolism, pathology)
  • Protein Tyrosine Phosphatase, Non-Receptor Type 6 (genetics, metabolism)
  • RNA Interference
  • Retinoblastoma Protein (genetics, metabolism)
  • Reverse Transcriptase Polymerase Chain Reaction
  • S Phase

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: